Second round of Covid vaccine booster shot in India starts today: 10 things to know
Premium
Second dose of vaccine being administered today to those who took the first shot on Day 1 of the nationwide inoculation drive on January 16th. Visuals from Delhi State Cancer Institute in GTB Nagar.
(ANI)
According to the doctors, the second round of Covid-19 vaccine booster dose is to be given to a beneficiary after a gap of 28 days
However, experts have clarified that the second shot can be taken anytime between four to six weeks from the first dose
Share Via
Read Full Story
The authorities are now gearing up for the roll-out of the second shot of coronavirus vaccination on Saturday for the beneficiaries who were given jabs at the beginning of the nationwide inoculation drive on 16 January.
The reasons for the lesser share of Covaxin include the reluctance of states in accepting the shots and supply issues by the manufacturer, officials at the ministry told this newspaper.
Updated on February 10, 2021
Indian Prime Minister Narendra Modi received a telephone call from Prime Minister of Canada Justin Trudeau regarding the COVID-19 vaccine situation. PM Trudeau informed PM Modi about Canada s requirements of COVID-19 vaccines from India. PM Modi assured its support.
Original article.
It didn t take long for political watchdogs to take note of a diplomatic anomaly between India and Canada. As India supplies vaccine to the world, at a time when Canada craves for a vaccine, then why would the two countries not indulge in this expected humanitarian exchange?
Prime Minister Narendra Modi with the Leaders of G20 Nations, at Hamburg, Germany on July 7, 2017. He is talking to Canadian Prime Minister Justin Trudeau. US President Donald Trump is also seen.Press Information Bureau
COVID-19 vaccine: Bharat Biotech likely to begin Covaxin trial on children by early March
The trials will begin in a Nagpur hospital and conducted in the age slabs of 2 to 5 years, 6 to 2 years and 12 to 18 years, teh first such attempt in the world.
Representative image: AP
Bharat Biotech is likely to begin Covaxin trial on children by February-end or early March 2021. The first phase of the trial will be conducted at a children s hospital in Nagpur, Maharashtra.
A city hospital has been picked where the trial will be undertaken on children aged between 2 and 12 and teenagers, the Times of India cited sources as saying. The trial will begin soon after the vaccine-maker receives the go-ahead from the medical regulator.
Image: Alamy
Pfizer has decided to give India a miss with its Covid-19 vaccine at least for now. On Friday, the pharma giant decided to withdraw its application for emergency use authorisation (EUA) of its vaccine, which it developed in association with Germany s BioNTech.
Pfizer, which is believed to have spent more than $2 billion developing the vaccine, was one of the first pharma companies to have applied for EUA in India. The pharma major applied for an EU with the Drugs Controller General of India (DCGI) in December. Subsequently, its India officials did not appear for a meeting with the regulator as bridging trial studies (trials on the Indian population) a necessary step for receiving marketing approval in the Indian market had not been conducted by them.